Dr. Kalbasi is a board-certified radiation oncologist and physician-scientist at the Stanford Cancer Institute. He is also an associate professor of radiation oncology at Stanford Medicine and a project member of the Parker Institute for Cancer Immunotherapy.
In the clinic, Dr. Kalbasi specializes in the diagnosis and treatment of solid tumors, especially sarcoma and melanoma, with a focus on bringing new treatments to patients. This focus includes using advanced techniques in radiation oncology and cancer immunotherapy.
Dr. Kalbasi's NIH-funded laboratory studies cancer immunology in the context of therapy (T cell therapy, cytokine, innate immune agonism, and radiotherapy). The lab has described tumor cell-, T cell- and myeloid cell-intrinsic mechanisms of resistance to therapy and novel approaches to overcome therapy resistance. Dr. Kalbasi is also an experienced leader of clinical trials related to immunotherapy, T cell therapy and radiation therapy.
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none